Prissm Pharma is a leading Trader, Exporter, and Wholesaler/Distributor of a number of Pharmaceutical products. With constant support of our proficient team members, we have gained a remarkable response from the industrial experts. Our product range Anti-Cancer Capsules, Anti Cancer Injectables, Anti Cancer Tablets, HIV Medicines, Daclatasvir Tablets, Hepatitis Vaccines, Myezom Vial Tablets and many more. With our highly learned professionals, we have gained valuable trust for providing medicinal products in a scheduled time frame. Further, our infrastructural facilities give us a huge support to offer all ordered goods in pre-decided time.
Company Facts:
Nature of Business
|
Exporter, Wholesaler/Distributor and Trader
|
Year of Establishment
|
1991
|
Company CEO
|
Amith Galaa
|
Industry
|
Trading and Exporter of Pharmaceutical Products.
|
Legal Status of Firm
|
Proprietorship Firm
|
Promoter
|
Mr. Amith Dhiraj Galaa
|
No. of Employees
|
10
|
Export Market
|
United States
|
Export Percentage
|
80-90%
|
Annual Turnover
|
Rs 1 Crore
|
Location Type
|
Semi-Urban
|
Building Infrastructure
|
Permanent
|
Size of Premises
|
550 square feet
|
Space Around
|
Front Porch
|
Banker
|
Kotak Mahindra Bank
|
PAN No.
|
AEZPG3682D
|
DGFT/IE Code
|
0305086499
|
Central Sales Tax No
|
27160709900C
|
Registration Authority
|
Maharashtra
|
Registration No.
|
760096379
|
Value Added Tax Registration No.
|
27160709900V
|
Warehousing Facility
|
Yes
|
Payment Mode
|
-
Cash
-
Cheque
-
DD
-
Credit Card
|
Shipment Mode
|
|
Our Products :
-
Anti
Cancer Capsules
-
Anti
Cancer Tablets
-
Hepcinat
400mg
-
Bondronat
Tablet
-
Revolade
Tablets
-
Sorafenat
Sorafenib Tablets
-
Onglyza
Tablet
-
Life
Saving Drugs Xbira Tablets
-
Soranib
Tablets
-
Inlyta
1 mg and 5 mg
-
Geftinat
Tablets
-
Altraz
Anastrozole Tablet
-
Votrient
Tablets
-
Erlonat
Tablet
-
Anti
Cancer Drug-Tykerb Tablet
-
Zytiga-Abiraterone
Acetate Tablets
-
Oncology
Drug-Veenat Tablet
-
Imatinib
Drug-Imatib Tablet
-
Tamoxifen
Tablet
|
-
Anti
Cancer Injectables
-
HIV
Medicines
-
Hepcinat
Tablets
|
|
|
|
|
We Mainly Deal in International Market.